Newsfeeds - Spark Newswire

1 minute read

SpringWorks Shares Pop After Expanded Multiple Myeloma Pact With GSK

Today, 11:13 PM

SpringWorks Therapeutics Inc (NASDAQ:SWTX) has entered into an expanded global, non-exclusive license and collaboration agreement with GSK plc (NYSE:GSK) for SpringWorks’ nirogacestat with…

GSK

21 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 11:13 PM

On Tuesday, 400 companies set new 52-week lows.

AAN

1 minute read

Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report

By Vandana Singh

Today, 11:13 PM

The European Union’s drugs regulator is just a few weeks away from deciding whether to approve Sanofi SA (NASDAQ:SNY) and GSK…

AZN

1 minute read

White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox

By Vandana Singh

Today, 11:13 PM

The White House is seeking $44.5 billion in emergency funding from Congress for Covid-19 and monkeypox and back…

AZN

8 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 11:13 PM

On Friday, 122 stocks hit new 52-week lows.

ACIW

28 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 11:13 PM

On Thursday, 529 companies set new 52-week lows.

$APE

13 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 11:13 PM

On Tuesday, 250 stocks hit new 52-week lows.

ACHV

1 minute read

With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report

By Vandana Singh

Today, 11:13 PM

Last week, Takeda Pharmaceutical Co Ltd’s (NYSE:TAK) dengue vaccine, Qdenga, was approved in Indonesia for individuals six to 45 years of age.…

GSK

15 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 11:13 PM

On Monday, 273 companies set new 52-week lows.

ABT

1 minute read

IDEAYA Achieves First Milestone In GSK Pact For Pol Theta Helicase Inhibitor Candidate

By Vandana Singh

Today, 11:13 PM

IDEAYA Biosciences Inc (NASDAQ:IDYA) has achieved a preclinical development milestone in connection with ongoing IND-enabling studies for its Pol Theta Helicase…

GSK